Format

Send to

Choose Destination
Nat Rev Cancer. 2013 Jun;13(6):397-411. doi: 10.1038/nrc3526.

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Author information

1
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. cheungn@mskcc.org

Abstract

Neuroblastoma is a solid tumour that arises from the developing sympathetic nervous system. Over the past decade, our understanding of this disease has advanced tremendously. The future challenge is to apply the knowledge gained to developing risk-based therapies and, ultimately, improving outcome. In this Review we discuss the key discoveries in the developmental biology, molecular genetics and immunology of neuroblastoma, as well as new translational tools for bringing these promising scientific advances into the clinic.

PMID:
23702928
PMCID:
PMC4386662
DOI:
10.1038/nrc3526
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center